1. Abdurasulova, N.N., Ekimova, I.V., Chernyshev, M.V., et al., Impairment to cognitive functions in Wistar rats in a model of the preclinical stage of Parkinson’s disease, Neurosci. Behav. Physiol., 2020, vol. 50, no. 4, pp. 439–450.
2. Ekimova, I.V., Gazizova, A.R., Karpenko, M.N., and Plaksina, D.V., Anhedonia features and destructive changes in the ventral region of the mesencephalic tegmentum in a modeled preclinical stage of Parkinson’s disease, Zh. Nevropatol. Psikhiatr. im. S. S. Korsakova, 2018, vol. 118, no. 9, pp. 61–67.
3. Ekimova, I.V., Plaksina, D.V., Pazi, M.B., and Nikotina, A.D., Chaperone inducer U133 in neuroprotective therapy strategies for Parkinson’s disease: an experimental study, Asimmetriya, 2018, vol. 12, no. 4, pp. 192–203.
4. Litvinenko, I.V., Kraskov, I.V., and Tikhomirova, O.V., Sleep disorders in Parkinson’s disease: pathophysiological mechanisms, clinical variants, and possible correction, in Bolezn’ Parkinsona i rasstroistva dvizhenii: Rukovodstvo dlya vrachei (Parkinson’s Disease and Movement Disorder: Manual for Physicians), Moscow, 2011, pp. 93–97.
5. Pastukhov, Yu.F., Changes in paradoxical sleep characteristics as an early feature of Parkinson’s disease, Zh. Nevropatol. Psikhiatr. im. S. S. Korsakova, 2013, vol. 63, no. 1, pp. 75–85.